Nicole A Traphagen

4PUBLICATIONS
25CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 27, 2026
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Nicole A Traphagen, Esmé Wheeler, Rong Li

|Jun 12, 2025
Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Nicole A Traphagen, Esmé Wheeler, Rong Li

|Jul 13, 2023
Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer.

Nicole A Traphagen, Gary N Schwartz, Steven Tau

|Mar 30, 2023
Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer.

Nicole A Traphagen, Gary N Schwartz, Steven Tau

Pageof 1